Welcome!
Home Pfizer Inc.
Covid-19
China vaccine's low efficacy due to high-risk group, says Sinovac CEO
Sinovac says the low efficacy rate of 50.38% from its final-stage trial in Brazil is due to participants being medical workers.
January 14, 2021
Covid-19
Pfizer to send US 100 million more vaccine doses
Pfizer shares gained 1.5% to US$37.29 at 10:09 a.m. in New York on Wednesday.
December 24, 2020
Covid-19
Here's where Pfizer's vaccine stands in Asia
The quick approval of Pfizer Inc.’s coronavirus vaccine in the UK isn’t likely to accelerate the availability of the shot in Asia.
December 03, 2020
Covid-19
UK becomes first western country to clear Pfizer-BioNTech Covid-19 vaccine
The UK has ordered enough doses of the two-shot Pfizer-BioNTech vaccine to immunize 20 million people.
December 02, 2020
Covid-19
Pfizer vaccine for Covid-19 on track for regulatory review in October
Pfizer Inc. and BioNTech SE said the vaccine was well tolerated with mild to moderate fever in fewer than 20% of the participants.
August 21, 2020